Boston Private Wealth LLC reduced its stake in shares of Aflac Incorporated (NYSE:AFL) by 9.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,600 shares of the financial services provider’s stock after selling 2,902 shares during the period. Boston Private Wealth LLC’s holdings in Aflac were worth $2,222,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. CWM LLC increased its position in Aflac by 2.1% in the second quarter. CWM LLC now owns 1,430 shares of the financial services provider’s stock worth $111,000 after buying an additional 30 shares during the last quarter. Harfst & Associates Inc. purchased a new position in Aflac during the first quarter worth about $128,000. Washington Trust Bank increased its position in Aflac by 0.9% in the second quarter. Washington Trust Bank now owns 1,704 shares of the financial services provider’s stock worth $132,000 after buying an additional 16 shares during the last quarter. ClariVest Asset Management LLC purchased a new position in Aflac during the second quarter worth about $150,000. Finally, Sit Investment Associates Inc. increased its position in Aflac by 1.8% in the second quarter. Sit Investment Associates Inc. now owns 2,137 shares of the financial services provider’s stock worth $166,000 after buying an additional 37 shares during the last quarter. 64.59% of the stock is currently owned by institutional investors.

Shares of Aflac Incorporated (NYSE:AFL) opened at 80.91 on Friday. The company’s 50 day moving average price is $79.41 and its 200-day moving average price is $75.36. Aflac Incorporated has a 52 week low of $66.50 and a 52 week high of $81.89. The stock has a market capitalization of $31.98 billion, a PE ratio of 12.23 and a beta of 0.99.

Aflac (NYSE:AFL) last released its quarterly earnings data on Thursday, July 27th. The financial services provider reported $1.83 EPS for the quarter, beating the consensus estimate of $1.63 by $0.20. Aflac had a return on equity of 13.09% and a net margin of 11.98%. The company had revenue of $5.43 billion for the quarter, compared to analyst estimates of $5.48 billion. During the same period last year, the company posted $1.65 earnings per share. The firm’s revenue was down .2% compared to the same quarter last year. Equities research analysts predict that Aflac Incorporated will post $6.69 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 1st. Shareholders of record on Wednesday, August 23rd will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 2.13%. The ex-dividend date is Monday, August 21st. Aflac’s dividend payout ratio (DPR) is presently 25.94%.

Aflac announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, August 8th that allows the company to buyback 40,000,000 shares. This buyback authorization allows the financial services provider to purchase shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

WARNING: “Aflac Incorporated (AFL) Shares Sold by Boston Private Wealth LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/26/aflac-incorporated-afl-shares-sold-by-boston-private-wealth-llc.html.

A number of equities analysts have recently issued reports on the company. ValuEngine raised Aflac from a “hold” rating to a “buy” rating in a research report on Tuesday, August 1st. BidaskClub downgraded Aflac from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Barclays PLC increased their price target on Aflac from $73.00 to $79.00 and gave the stock an “equal weight” rating in a research report on Friday, August 11th. FBR & Co reissued a “market perform” rating and set a $80.00 price target (up previously from $68.00) on shares of Aflac in a research report on Wednesday, July 12th. Finally, Royal Bank Of Canada reissued a “sell” rating and set a $66.00 price target on shares of Aflac in a research report on Wednesday, July 12th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. Aflac currently has an average rating of “Hold” and an average price target of $76.50.

In other Aflac news, Director Karole Lloyd bought 1,000 shares of the stock in a transaction dated Monday, June 12th. The stock was bought at an average cost of $77.01 per share, for a total transaction of $77,010.00. Following the completion of the purchase, the director now directly owns 7,253 shares of the company’s stock, valued at $558,553.53. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Kriss Cloninger III sold 2,500 shares of the firm’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $77.72, for a total value of $194,300.00. Following the sale, the president now owns 241,646 shares of the company’s stock, valued at $18,780,727.12. The disclosure for this sale can be found here. Insiders sold 240,203 shares of company stock worth $18,612,224 over the last three months. 3.00% of the stock is currently owned by corporate insiders.

Aflac Company Profile

Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company’s insurance business consists of two segments: Aflac Japan and Aflac U.S.

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Stock Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related stocks with our FREE daily email newsletter.